Gl. Snyder et al., PHOSPHORYLATION OF DARPP-32 IS REGULATED BY GABA IN RAT STRIATUM AND SUBSTANTIA-NIGRA, Journal of neurochemistry, 63(5), 1994, pp. 1766-1771
In the medium-sized spiny neurons of the striatonigral pathway, a casc
ade of events involving the activation of dopamine D-1 receptors, an i
ncrease in cyclic AMP, and activation of cyclic AMP-dependent protein
kinase causes the phosphorylation of DARPP-32 on Thr(34), converting D
ARPP-32 into a powerful inhibitor of protein phosphatase-1. In the pre
sent study, the incubation of striatal or substantia nigra slices with
GABA also increased the phosphorylation of DARPP-32 on Thr(34). GABA
did not significantly increase cyclic AMP levels in slices. The phosph
orylation of DARPP-32 by GABA was blocked in both brain regions by pre
treatment of slices with the GABA(A) receptor antagonist, bicuculline,
but not with the GABA(B) receptor antagonist, phaclofen. Moreover, th
e threonine phosphorylation of DARPP-32 produced by maximally effectiv
e doses of either forskolin (in striatum) or L-3,4-dihydroxyphenylalan
ine (in substantia nigra) was increased further by GABA. The data are
consistent with a model in which GABA increases the phosphorylation st
ate of DARPP-32 by inhibiting dephosphorylation of the protein by the
calcium/calmodulin-dependent protein phosphatase, calcineurin.